Bibliography
Aicardi J, Goutieres F. [Neonatal myoclonic encephalopathy (author's transl)]. Rev Electroencephalogr Neurophysiol Clin. 1978;8:99-101.
Atakli D, Sozuer D, Atay T, Baybas S, Arpaci B. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure. 1998;7:63-66.
Barron TF, Hunt SL, Hoban TF, Price ML. Lamotrigine monotherapy in children. Pediatr Neurol. 2000;23:160-163.
Bello-Espinosa LE, Roberts SL. Levetiracetam for benign epilepsy of childhood with centrotemporal spikes: three cases. Seizure. 2003;12:157-159.
Ben-Menachem E, Gilland E. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Seizure. 2003;12:131-135.
Berg AT, Shinnar S, Levy SR, Testa FM, Smith-Rapaport S, Beckerman B. How well can epilepsy syndromes be identified at diagnosis? A reassessment 2 years after initial diagnosis. Epilepsia. 2000;41:1269-1275.
Berkovic SF, Kennerson ML, Howell RA, Scheffer IE, Hwang PA, Nicholson GA. Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20. Arch Neurol. 1994;51:1125-1128.
Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 1999;52:1330-1337.
Biton V, Bourgeois BFD, Le K, for the YTC/YTC-E Study Investigators. Arch Neurol. In press.
Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia. 2001;42:1212-1218.
Bourgeois B, Beaumanoir A, Blajev B, et al. Monotherapy with valproate in primary generalized epilepsies. Epilepsia. 1987;28(suppl 2):S8-S11.
Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure. 1996;5:149-151.
Callaghan N, O'Hare J, O'Driscoll D, O'Neill B, Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol. 1982;24:830-836.
Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356:1638-1642.
Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia. 1991;32:69-76.
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30:389-399.
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489-501.
Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia. 1995;36:1017-1024.
Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984;34:285-294.
Dhuna A, Pascual-Leone A, Talwar D. Exacerbation of partial seizures and onset of nonepileptic myoclonus with carbamazepine. Epilepsia. 1991;32:275-278.
Donat JF, Wright FS. Seizures in series: similarities between seizures of the west and Lennox-Gastaut syndromes. Epilepsia. 1991;32:504-509.
Dravet C, Bureau M, Roger J. Severe myoclonic epilepsy in infants. In: Dravet C, Bureau M, Roger J, eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey & Co Ltd; 1985:58-67.
Dulac O, Figueroa D, Rey E, Arthuis M. [Monotherapy with clobazam in epilepsies in children]. Presse Med. 1983;12:1067-1069.
Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42:796-803.
Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood encephalopathy (Lennox-Gastaut Syndrome). N Engl J Med. 1993;328:29-33.
Fernando-Dongas MC, Radtke RA, VanLandingham KE, Husain AM. Characteristics of valproic acid resistant juvenile myoclonic epilepsy. Seizure. 2000;9:385-388.
Fisher RS, van Emde Boas W, Blume, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46:470-472.
Foldvary-Schaefer N, Wyllie E. Epilepsy. In: Goetz CG, ed. Textbook of Clinical Neurology. Philadelphia, Pa: Saunders; 2003:1155-1176.
Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia. 1999;40:973-979.
French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1252-1260.
Gibbs FA, Gibbs EL. Epilepsy. In: Gibbs FA, Gibbs EL, eds. Atlas of Electroencephalography 2. Cambridge, Mass: Addison-Wesley; 1952.
Greenhill L, Betts T, Smith K. Effect of levetiracetam on resistant juvenile myoclonic epilepsy [abstract]. Epilepsia. 2001;42(suppl 7):179. Abstract 2.243.
Hauser WA. Seizure disorders: the changes with age. Epilepsia. 1992;33(suppl 4):S6-S14.
Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34:453-468.
Husain AM, Mateen F, Radtke RA. Utility of levetiracetam in monotherapy in patients with partial and generalized epilepsies [abstract]. Epilepsia. 2002;43(suppl 7):193-194. Abstract 2.190.
Janz D, Inoue Y, Seino M. Mycoclonic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, Pa: Lippincott-Raven;1997:591-603.
Kleveland G, Engelsen BA. Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure. 1998;7:31-38.
Krauss GL, Betts T, Abou-Khalil B, Gergey G, Yarrow H, Miller A. Levetiracetam treatment of idiopathic generalised epilepsy. Seizure. 2003;12:617-620.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
Lewis TB, Leach RJ, Ward K, O'Connell P, Ryan SG. Genetic heterogeneity in benign familial neonatal convulsions: identification of a new locus on chromosome 8q. Am J Hum Genet. 1993;53:670-675.
Lippmann SM, Montouris GD, Rosenfeld WE, Schaefer PA. Levetiracetam: a helpful new drug. Epilepsia. 2002;43(suppl 7):295. Abstract 3.136.
Loiseau P, Duche B, Loiseau J. Classification of epilepsies and epileptic syndromes in two different samples of patients. Epilepsia. 1991;32:303-309.
Lombroso CT, Fejerman N. Benign myoclonus of early infancy. Ann Neurol. 1977;1:138-143.
Ma CK, Chan KY. Benign childhood epilepsy with centrotemporal spikes: a study of 50 Chinese children. Brain Dev. 2003;25:390-395.
Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology. 2004;62:1668-1681.
Miles DK, Holmes GL. Benign neonatal seizures. J Clin Neurophysiol. 1990;7:369-379.
Mitsudome A, Ohfu M, Yasumato S, et al. The effectiveness of clonazepam on the Rolandic discharges. Brain Dev. 1997;19:274-278.
Mohanraj R, Parker PG, Kelly K, Stephen LJ, Sills GJ, Brodie MJ. Clinical experience with levetiracetam: a prospective observational study [abstract]. Epilepsia. 2002;43(suppl 7):196-197. Abstract 2.199.
Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997;337:1807-1812.
Mullin P, Stern JM, Delgado-Escueta AV, Eliashiv D. Effectiveness of open-label zonisamide in juvenile myoclonic epilepsy [abstract]. Epilepsia. 2001;42(suppl 7):184. Abstract 2.260.
Nabbout R, Gennaro E, Dalla Bernardina B, et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology. 2003;60:1961-1967.
Nordli DR Jr, Bazil CW, Scheuer ML, Pedley TA. Recognition and classification of seizures in infants. Epilepsia. 1997;38:553-560.
Nordli DR Jr, Kuroda MM, Hirsch LJ. The ontogeny of partial seizures in infants and young children. Epilepsia. 2001;42:986-990.
Obeid T, Panayiotopoulos CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia. 1989;30:603-606.
Ohtahara S. Clinico-electrical delineation of epileptic encephalopathies in childhood. Asian Med J. 1978;21:499-509.
Ottman R. An Overview of Human Epilepsy Genes. In: Epilepsy in the New Era of the Human Genome. 2002: Seattle, WA. Slide presentation at the 22nd Annual Merritt-Putnam Symposium.
Penry JK, Dean JC, Riela AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia. 1989;30(suppl 4):S19-S23; discussion S17-S24.
Rating D, Wolf C, Bast T. Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group. Epilepsia. 2000;41:1284-1288.
Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology. 1990;40:1677-1681.
Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology. 1993;43:1355-1360.
Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology. 1999;52:1882-1887.
Sato S, White BG, Penry JK, Dreifuss FE, Sackellares JC, Kupferberg HJ. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology. 1982;32:157-163.
Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 1997;120(pt 3):479-490.
Sharpe C, Buchanan N. Juvenile myoclonic epilepsy: diagnosis, management and outcome. Med J Aust. 1995;162:133-134.
Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 1998;18:25-29.
Spampanato J, Aradi I, Soltesz I, Goldin AL. Increased neuronal firing in computer simulations of sodium channel mutations that cause generalized epilepsy with febrile seizures plus. J Neurophysiol. 2004;91:2040-2050.
Stables JP, Bertram E, Dudek FE, et al. Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia. 2003;44:1472-1478.
Stafstrom CE, Tempel BL. Epilepsy genes: the link between molecular dysfunction and pathophysiology. Ment Retard Dev Disabil Res Rev. 2000;6:281-292.
Sugawara T, Tsurubuchi Y, Fujiwara T, et al. Nav1.1 channels with mutations of severe myoclonic epilepsy in infancy display attenuated currents. Epilepsy Res. 2003;54:201-207.
Sundqvist A, Tomson T, Lundkvist B. Valproate as monotherapy for juvenile myoclonic epilepsy: dose-effect study. Ther Drug Monit. 1998;20:149-157.
Task Force on Epilepsy Classification and Terminology [ILAE Web site]. Available at http://www.ilae-epilepsy.org/Visitors/Centre/ctf/. Accessed August 26, 2005.
Timmings PL, Richens A. Efficacy of lamotrigine as monotherapy for juvenile myoclonic epilepsy: pilot study results [abstract]. Epilepsia. 1993;34(suppl 2):160
Trinka E, Unterrainer J, Unterberger I, Luef G, Deisenhammer F, Bauer G. One-year postmarketing experience with levetiracetam for treatment of drug-resistant epilepsy: a cross-sectional study. Epilepsia. 2002;43(suppl 7):202. Abstract 2.215.
Trudeau V, Myers S, LaMoreaux L, Anhut H, Garofalo E, Ebersole J. Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol. 1996;11:470-475.
Vigerano F, Fusco L, Yagi K, Seino M. Tonic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia, Pa: Lippincott-Raven;1997:617-625.
Wallace RH, Hodgson BL, Grinton BE, et al. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology. 2003;61:765-769.
Watanabe K, Miura K, Natsume J, Hayakawa F, Furune S, Okumura A. Epilepsies of neonatal onset: seizure type and evolution. Dev Med Child Neurol. 1999;41:318-322.
West WJ. On a peculiar form of infantile convulsions. Lancet. 1841;36:724-725.
Wolf P. Juvenile absence epilepsy [ILAE Web site]. Available at http://www.ilae-epilepsy.org/Visitors/Centre/ctf/juvenile_absence.cfm. Accessed August 26, 2005.